Key result
Stable obesity over a 33-year period was associated with an increased risk of elevated cardiac troponin I compared to stable normal weight (OR 1.70; 95% CI 1.33-2.17; p<0.001).
Why the study?
Whether lifetime excess weight history is associated with increased cTnI concentrations, and how abdominal adiposity and glycemic dysregulation affect these associations, remained unclear.
Does a lifetime history of stable overweight or obesity increase the risk of subclinical myocardial injury (elevated cTnI) in a general population cohort?
Cohort (n=9,739)
Does a lifetime history of stable overweight or obesity increase the risk of subclinical myocardial injury (elevated cTnI) in a general population cohort?
Long-standing stable overweight or obesity is associated with an increased risk of subclinical myocardial injury, independent of glycemic dysregulation and abdominal adiposity.
Long-term obesity may flag subclinical injury risk; leaves open whether weight loss modifies troponin trajectories in trials.
BACKGROUND: Obesity is associated with subclinical myocardial injury as quantified by concentrations of cardiac troponin T, but whether lifetime excess weight history is associated with increased concentrations of cardiac troponin I (cTnI) and how indices of abdominal adiposity and glycemic dysregulation affect these associations remain unclear. METHODS: We analyzed cTnI with a high-sensitivity assay in 9739 participants in the Trøndelag Health (HUNT) Study at study visit 4 (2017-2019). BMI was assessed at study Visit 1 (1984-1986), 2 (1995-1997), 3 (2006-2008), and 4. RESULTS: Median age at visit 4 was 68.7 years and 59% were women. Concentrations of cTnI were detectable in 84.1% of study participants, with a median of 2.5 (1.5-4.5 ng/L). We identified three clusters of BMI trajectories from visit 1 to 4, (1) stable normal weight, (2) stable overweight, and (3) stable obesity. Participants in clusters 2 and 3 were at increased risk of elevated concentrations of cTnI at visit 4 (odds ratio 1.27, 95% CI 1.09-1.47, and odds ratio 1.70, 95% CI 1.33-2.17, p for trend <0.001). Participants in cluster 3 had 22.0 (95% CI 14.1-29.9) higher concentrations of cTnI compared to participants in cluster 1 (p for trend <0.001). Dysregulated glucose metabolism and abdominal obesity did not influence our results. CONCLUSIONS: Individuals with stable overweight or obesity are at increased risk of subclinical myocardial injury, independently of glycemic dysregulation and abdominal adiposity. Our data support a direct detrimental effect of long-standing obesity on cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Lyngbakken et al. (2021) conducted a cohort in Subclinical myocardial injury (n=9,739). Stable obesity (BMI trajectory) vs. Stable normal weight was evaluated on Elevated concentrations of cardiac troponin I (OR 1.70, 95% CI 1.33-2.17, p=<0.001). Stable obesity over a 33-year period was associated with an increased risk of elevated cardiac troponin I compared to stable normal weight (OR 1.70; 95% CI 1.33-2.17; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: